{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-114466","form_type":"8-K","ticker":"BOLD","cik":"0001782303","company_name":"Boundless Bio, Inc.","filed_at":"2024-10-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.593398+00:00","generated_at":"2026-05-30T14:40:53.991004+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Boundless Bio CFO Jami Rubin steps down; David Hinkle named principal financial officer","bullets":["Jami Rubin resigned as CFO and Treasurer effective October 11, 2024.","David Hinkle, SVP Finance & Controller, appointed as Treasurer, principal financial officer and principal accounting officer.","Rubin eligible for severance per company's Severance Plan as a Tier 2 employee.","Hinkle joined Boundless Bio in 2021; prior roles at Crinetics Pharmaceuticals, Ignyta, Receptos."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-114466","json":"https://secwatch.observer/filing/0000950170-24-114466.json","markdown":"https://secwatch.observer/filing/0000950170-24-114466.md","text":"https://secwatch.observer/filing/0000950170-24-114466.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1782303/000095017024114466/0000950170-24-114466-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1782303/000095017024114466/bold-20241011.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T14:40:53.991004+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"07d2ebcd7d","claim":"Jami Rubin departed as Chief Financial Officer and Treasurer at Boundless Bio, Inc..","evidence_excerpt":"On October 14, 2024, Boundless Bio, Inc. (the “Company”) announced that Jami Rubin, the Company’s Chief Financial Officer and Treasurer, stepped down from her role with the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1782303/000095017024114466/0000950170-24-114466-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"stepped down"},{"label":"Role","value":"Chief Financial Officer and Treasurer"}],"fact_type":"executive_change"},{"claim_id":"644dec4248","claim":"David Hinkle was appointed as Treasurer, principal financial officer, and principal accounting officer at Boundless Bio, Inc..","evidence_excerpt":"As of the Effective Date, David Hinkle, the Company’s Senior Vice President, Finance & Controller, was appointed to also serve as the Company’s Treasurer, principal financial officer, and principal accounting officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1782303/000095017024114466/0000950170-24-114466-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Treasurer, principal financial officer, and principal accounting officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}